Nucala 100 mg/mL, Injektionslösung in der Fertigspritze
7680673510018
CH-67351
Injektionslösung
Associated product:
NUCALA sol inj 100 mg/ml seringue préremplie
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1078.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2020
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 67351
- Drug name
- Nucala, Injektionslösung in der Fertigspritze
- Galenic form
- INLFS
- ATC Code
- R03DX09
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 13/02/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 03.04.5.
- Domain
- Human medicine
Package details
- Description (FR)
- NUCALA sol inj 100 mg/ml seringue préremplie
- Description (DE)
- NUCALA Inj Lös 100 mg/ml Fertigspritze
- Market launch
- 13/02/2020
- Narcotic (BTM)
- No
Other package sizes (1)
None
3 x 1 FESP
GTIN: None